About Nanorobotics

Nanorobotics is a preclinical-stage startup on a mission to eradicate cancer by harnessing the power of its breakthrough, patented light-activated nanomolecular platform technology.

MANAGEMENT

Yossi Keret

CEO & CO-FOUNDER​
Business executive with a proven track record in financing, fundraising, performing IPOs, and managing private and publicly-traded companies.

Dr. Shlomo Nedvetzki

CTO
Extensive management experience in the drug development and medical device fields. Proven experience in developing products from research, through pre-clinical and clinical stages.

Ahuva Zohar

CFO
Over 20 years of financial experience in private and publicly traded high-tech and biotech companies. Extensive knowledge in financial management of international activity.

Dr. Danny Fishelovitch

Head of CMC
With more than 14 years of experience in pharmaceutical industry. He has lead CMC teams in Teva Pharmaceuticals, NeuroDerm and Enlivex Therapeutics. Danny holds Ph.D. in Structural Biology from Tel-Aviv University.

Dr. Doron Shinar

Head of Pre-clinical
A former head of the Non-Clinical Safety Department of Teva Pharmaceuticals leading international teams of pre-clinical scientists. Over 30- years of experience in drug development in the Pharmaceutical Industry and in toxicological assessments.

Yossi Keret

CEO & CO-DOUNDER

Business executive with a proven track record in financing, fundraising, performing IPOs, and managing private and publicly-traded companies.

Dr. Shlomo Nedvetzki

CTO

Extensive management experience in the drug development and medical device fields. Proven experience in developing products from research, through pre-clinical and clinical stages.

Ahuva Zohar

CFO

Over 20 years of financial experience in private and publicly traded high-tech and biotech companies. Extensive knowledge in financial management of international activity.

Dr. Danny Fishelovitch

Head of CMC

With more than 14 years of experience in pharmaceutical industry. He has lead CMC teams in Teva Pharmaceuticals, NeuroDerm and Enlivex Therapeutics. Danny holds Ph.D. in Structural Biology from Tel-Aviv University.

Dr. Doron Shinar

Head of Pre-Clinical

A former head of the Non-Clinical Safety Department of Teva Pharmaceuticals leading international teams of pre-clinical scientists. Over 30- years of experience in drug development in the Pharmaceutical Industry and in toxicological assessments.

BOARD OF DIRECTORS

Yossi Keret

Doron Gavish

Avishay Goldberg

John van Leeuwen

Ben Tour

Guy Hoffman

SCIENTIFIC ADVISORY BOARD MEMBERS

Dr. Michael Ziv

MD – Head of Dermatology Department

"Emek" Medical Center, Afula

Prof. Yuval Ramot

MD – Senior Dermatologist

"Hadassah" Medical Center, Jerusalem

Dr. Steve Hubert

MD – Lawrenceville Dermatology Associates

PC, NJ

Skip to content